| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18620765 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 103 journal articles in the PubMed database | Email to a friend | | |
| Wahlin M, Albertsson P, Karlsson T, et al.
Switch from abciximab to eptifibatide during percutaneous coronary intervention. [JOURNAL ARTICLE]
Int J Cardiol 2008 Jul 10.
Abstract | Full Citation | Find Related Articles | | Suleiman M, Gruberg L, Hammerman H, et al.
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention. [Journal Article]
J Invasive Cardiol 2003 Jun; 15(6):319-23.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kimmelstiel C, Phang R, Rehman A, et al.
Short-term comparative outcomes associated with the use of GP IIb/IIIa antagonists in patients undergoing coronary intervention. [Journal Article]
J Thromb Thrombolysis 2001 May; 11(3):203-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Midei MG, Coombs VJ, Lowry DR, et al.
Clinical Outcomes Comparing Eptifibatide and Abciximab in ST Elevation Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions. [JOURNAL ARTICLE]
Cardiology 2006 Aug 28; 107(3):172-177.
Abstract | Full Citation | Find Related Articles | | Gurm HS, Smith DE, Collins JS, et al.
The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. [Comparative Study, Journal Article]
J Am Coll Cardiol 2008 Feb 5; 51(5):529-35.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | |
Comparative 30-day economic and clinical outcomes of platelet glycoprotein IIb/IIIa inhibitor use during elective percutaneous coronary intervention: Prairie ReoPro versus Integrilin Cost Evaluation (PRICE) Trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am Heart J 2001 Mar; 141(3):402-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Galli M, Maggioni AP, Vassanelli C, et al.
[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type] [Journal Article, Review]
Ital Heart J Suppl 2000 Feb; 1(2):202-11.
Abstract | Full Citation | Find Related Articles | | Ajani AE, Waksman R, Gruberg L, et al.
Acute procedural complications and in-hospital events after percutaneous coronary interventions: eptifibatide versus abciximab. [Journal Article]
Cardiovasc Radiat Med 2003 Jan-Mar; 4(1):12-7.
Abstract | Full Citation | Find Related Articles | | Lincoff AM, Kleiman NS, Kereiakes DJ, et al.
Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
JAMA 2004 Aug 11; 292(6):696-703.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
